Christopher R. Cline

Insider Reports History

Entity
Individual
Location
C/O Travere Therapeutics, Inc., 3611 Valley Centre Drive, Ste 300, San Diego, CA
Signature
/s/ Elizabeth E. Reed, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher R. Cline:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Travere Therapeutics, Inc. CHIEF FINANCIAL OFFICER Common Stock 74.6K $859K $11.52 Sep 9, 2024 Direct
Travere Therapeutics, Inc. CHIEF FINANCIAL OFFICER Employee stock option (right to buy) 65K Jan 31, 2024 Direct

Insider Reports Filed by Christopher R. Cline

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TVTX Travere Therapeutics, Inc. Sep 5, 2024 2 -$28.7K 4 Sep 9, 2024 CHIEF FINANCIAL OFFICER
TVTX Travere Therapeutics, Inc. Sep 4, 2024 1 -$4.89K 4 Sep 5, 2024 CHIEF FINANCIAL OFFICER
TVTX Travere Therapeutics, Inc. Apr 11, 2024 1 -$364 4 Apr 12, 2024 CHIEF FINANCIAL OFFICER
TVTX Travere Therapeutics, Inc. Jan 31, 2024 3 -$32.6K 4 Feb 2, 2024 CHIEF FINANCIAL OFFICER
TVTX Travere Therapeutics, Inc. Jan 23, 2024 1 -$7.74K 4 Jan 25, 2024 CHIEF FINANCIAL OFFICER
TVTX Travere Therapeutics, Inc. Sep 5, 2023 1 -$6.72K 4 Sep 5, 2023 Chief Financial Officer
TVTX Travere Therapeutics, Inc. May 10, 2023 1 -$7.55K 4 May 12, 2023 Chief Financial Officer
TVTX Travere Therapeutics, Inc. Apr 11, 2023 1 -$1.01K 4 Apr 13, 2023 Chief Financial Officer
TVTX Travere Therapeutics, Inc. Jan 31, 2023 4 -$34.5K 4 Feb 2, 2023 Chief Financial Officer
TVTX Travere Therapeutics, Inc. Jan 24, 2023 1 -$18.7K 4 Jan 26, 2023 Chief Financial Officer
TVTX Travere Therapeutics, Inc. Sep 1, 2022 3 $0 4 Sep 1, 2022 Chief Financial Officer
TVTX Travere Therapeutics, Inc. Sep 1, 2022 0 $0 3 Sep 1, 2022 Chief Financial Officer